In the third part of the Harm Reduction episode, we focus on the work accomplished by Villa Maraini.
Villa Maraini, founded in 1976 by the Italian Red Cross, is committed to improving prevention services and access to harm reduction resources, while linking people living with viral hepatitis and HIV into care. Join Dr. Mauro Zaccarelli, Head of the HIV Unit at Villa Maraini, as he shares the work that the organization has been doing to support the people living with hepatitis and HIV in Italy, including mobile clinics and community outreach efforts.
For more information about Villa Maraini, visit:
Website: villamaraini.it/
Facebook: / fondazionevillamaraini
Twitter: / villamaraini
For more information about Gilead, visit:
Website: www.gilead.com
Stories@Gilead: stories.gilead.com
Twitter: / gileadsciences
LinkedIn: / gileadsc. .
Instagram: / gileadsciences
Facebook: / gileadsciences
About Gilead
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
This webinar episode was created and fully funded by Gilead Sciences, Inc. GILEAD, the GILEAD logo, and the & design are trademarks of Gilead Sciences, Inc. © 2023 Gilead Sciences, Inc. All rights reserved.